CIAM
DFTX

Caitong International Asset Management’s Definium Therapeutics DFTX Stock Holding History

Caitong International Asset Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76.3K Buy
4,036
+4,021
+26,807% +$68.2K 0.01% 660
2025
Q4 		$201 Buy
+15
New +$186 ﹤0.01% 1620
2025
Q3 		– Sell
-341
Closed -$2.21K – 2293
2025
Q2 		$2.21K Sell
341
-218
-39% -$1.43K ﹤0.01% 1350
2025
Q1 		$3.27K Buy
+559
New +$4K ﹤0.01% 1152

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Caitong International Asset Management's DFTX Position: Q1 2026 in Review

Caitong International Asset Management increased its Definium Therapeutics (DFTX) stake by 26,807% in Q1 2026, buying an estimated $68.2K and bringing the position to 4,036 shares worth $76.3K. The position accounts for 0.01% of the portfolio, ranked #660.

Caitong International Asset Management first reported a position in DFTX in Q1 2025 and has held it in 4 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Caitong International Asset Management held 4,036 shares of Definium Therapeutics worth $76.3K as of Q1 2026.
  • Caitong International Asset Management bought 4,021 Definium Therapeutics shares in Q1 2026, an estimated $68.2K.
  • Definium Therapeutics made up 0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #660 holding.
  • Caitong International Asset Management first reported a position in Definium Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.